semaglutide approval for mash CDSCO Clears Wegovy — India's First GLP-1 for Liver Disease, India's drug regulator CDSCO approved Novo Nordisk's Wegovy (semaglutide 2.4mg) on 17 July 2026 for MASH, based on FDA Grants Accelerated Approval to

They've just been surpassed by better compounds that cost about the same and work significantly better

That is not the agency saying the safety concerns went away

TorHoerman Law is actively investigating potential legal claims on behalf of individuals and families harmed by recreational nitrous oxide use

A small catheter goes into a vein in the arm or hand, much like a routine blood draw, and the IV drips begin

Unlike traditional weight loss programs that hinge on rigid protocols or overpromise dramatic results, Sprout Health is recognized for setting realistic expectations and prioritizing lifestyle balance

If guided self-help is declined, ineffective, or unavailable, NICE recommends offering a specifically adapted form of cognitive behavioural therapy (CBT-ED), typically delivered over 1620 sessions